Kiadis Pharma
- Kiadis Pharma floated on Euronext Amsterdam and Euronext Brussels
- Proceeds of the IPO will be used to advance the clinical development of the lead products
- Kempen & Co acted as Sole Global Coordinator and Joint Bookrunner in the transaction